VideoHIVInternational Workshop on HIV Pediatrics 2020Twenty-Four Week Safety, Tolerability and Efficacy of Dolutegravir Dispersible Tablets in Children 4 Weeks to <6 Years Old with HIV: Results from IMPAACT P1093 - Theodore RuelView Video
SlidesetHIVInternational Workshop on HIV Pediatrics 2020SARS-Cov-2 Vaccines - Anthony FauciView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2020Clinical Illness Including MIS-C - Elizabeth WhittakerView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2020School/Daycare - Moherndran ArcharyView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2020Susceptibility and Ability to Transmit - Lynne MofensonView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2020Prevention of Mother To Child HIV Transmission - Global Gaps and Potential Solutions - Benjamin ChiView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2020PrEP in Pregnancy and Breastfeeding: the Why, What and How - Jillian PintyeView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2020The "Why, When and How To" of HIV Disclosure: Perspectives from the North and South - Ann PetruView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2020Is U=U Applicable to Breastfeeding? - Lynne MofensonView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2020Advances in Cure Research Across the Lifespan - Dan KuritzkesView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2020The HIV Epidemic in Infants, Children, Adolescents and Women Today - 2020 UNAIDS Update - Mary MahyView Slideset
